Skip to main content
. 2026 Sep 14;18(9):1152. doi: 10.3390/pharmaceutics18091152
ADH alcohol dehydrogenase
ADME absorption, distribution, metabolism, and excretion (in this review, the fourth process is treated as clearance-like removal, since in vitro skin models have no excretory function)
AHT 4-amino-2-hydroxytoluene
AMT total cumulative amount permeated
BCRP breast cancer resistance protein
CBM cutaneous biodistribution method
COMT catechol-O-methyltransferase
CRS confocal Raman spectroscopy
CYP cytochrome P450
dOFM dermal open-flow microperfusion
EFSA European Food Safety Authority
EHS ex vivo human skin
EMA European Medicines Agency
ER electrical resistance
FDA U.S. Food and Drug Administration
FMO flavin-containing monooxygenase
FTSE full-thickness skin equivalent
GelMA gelatin methacryloyl
GST glutathione S-transferase
HPLC high-performance liquid chromatography
IVIVE in vitro–in vivo extrapolation
IVPT in vitro permeation testing
IVRT in vitro release testing
LC–MS liquid chromatography–mass spectrometry
LSE living skin equivalent
MALDI matrix-assisted laser desorption/ionization
MIVO multi-in-vitro-organ (microphysiological platform)
MPS microphysiological system
MRP multidrug resistance-associated protein
MSI mass spectrometry imaging
NAT N-acetyltransferase
OECD Organisation for Economic Co-operation and Development
PBPK physiologically based pharmacokinetic
PDMS poly(dimethylsiloxane)
P-gp P-glycoprotein
RHE reconstructed human epidermis
SC stratum corneum
TEWL transepidermal water loss
TG Test Guideline
UGT UDP-glucuronosyltransferase
UHPLC–MS/MS ultra-high-performance liquid chromatography–tandem mass spectrometry
XME xenobiotic-metabolizing enzyme
A exposed diffusion area
Cd dissolved donor concentration in contact with the barrier
Cin, Cout compound concentration in the inlet and outlet perfusate
CLapp apparent concentration-normalized clearance
Cref concentration in the compartment from which the compound is removed
Deff effective diffusion coefficient
Jmax maximum flux
Jpeak peak flux under finite-dose conditions
Jss steady-state flux
Kp apparent permeability coefficient
Q(t) cumulative amount permeated per unit area
Qf volumetric flow rate
Sv saturation solubility of the compound in the applied vehicle
tlag lag time
tpeak time of peak flux